-+ 0.00%
-+ 0.00%
-+ 0.00%

Neurocrine Biosciences Announces R&D Strategy Focused on Advancing Novel Therapies in Neuroscience and Endocrinology, Expanding CRF Platform for Metabolic Diseases, and Targeting Multiple New Medicine Approvals by Decade’s End

路透·12/16/2025 21:01:19

登錄查看新聞詳情